Prevalence and Clinical Correlates of Intracranial Dolichoectasia in Individuals With Ischemic Stroke

Novel classification of brain vascular tortuosity measures: A systematic review

Given the absence of a standardized measure for evaluating tortuosity in cerebrovascular images, our investigation focuses on the methods used to estimate vascular tortuosity over the past decade. The main purpose is to create a useful, easily accessible guide to tortuosity estimation methods for brain researchers and clinicians. We conducted a systematic literature review in PUBMED and Scopus from 2013 to 2023 for tortuosity index (TI) analysis of human cerebrovascular images providing either quantitative or qualitative tortuosity measures. A total of 111 articles reporting TI measures were identified, in which 16 different TI were used to analyze 29 different diseases in Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Digital Subtraction Angiography (DSA), Ultrasound images (US), and other Magnetic Resonance Imaging (MRI) sequences. A novel categorization of tortuosity indices is suggested, based on the nature of the metrics. This classification comprises four categories: morphological-based, ratio distance-based, trigonometrical-based, and curvature-based methods. A TI Metric guide is proposed to facilitate the selection of the optimal TI for each use case. Our results show that Distance Metric (DM) is the most used, simple, and versatile method of capturing tortuous patterns, making it a preferred choice among researchers studying different disease contexts. Conversely, healthcare practitioners often prefer the Weibel and Fields tortuosity metric due to its categorical output, which offers a simplified and readily interpretable classification that complements clinical decision-making processes effectively.

Vessel wall enhancement in vertebrobasilar dolichoectasia is associated with posterior circulation infarction: An observational study based on high-resolution magnetic resonance imaging

BACKGROUND

Posterior circulation infarction (PCI) is the most common manifestation of vertebrobasilar dolichoectasia (VBD). Vessel wall enhancement (VWE) in high-resolution magnetic resonance imaging (HR-MRI) is associated with ischemic stroke.

OBJECTIVES

This study aims to evaluate different quantitative VWE parameters in identifying PCI in VBD patients by comparing the sensitivity of each VWE parameter. The associated factors of PCI and VWE were also identified.

METHODS

Patients with VBD who received HR-MRI were retrospectively analyzed and divided into PCI and non-PCI groups. Morphological parameters of VBD were measured using magnetic resonance angiography. VWE parameters, including arterial-to-pituitary stalk contrast ratio (CRstalk), arterial enhancement index, and arterial enhancement ratio, were extracted and calculated. The receiver-operating characteristic curve was used to compare the sensitivity of VWE parameters in discriminating PCI. The independent factors associated with PCI and VWE were investigated.

RESULTS

A total of 140 patients with VBD were included. Forty patients (28.6 %) had PCI. CRstalk with the average signal intensity (CRstalk-avg) had the highest sensitivity in identifying PCI with an area under curve value of 0.783 and a cut-off value of 0.47. CRstalk-avg (OR = 2.908, p < 0.001) and basilar artery tortuosity index (BATI) (OR = 1.391, p = 0.033) were independently associated with PCI. The independent associated factors of VWE were BA diameter (OR = 4.273, p < 0.001), BATI (OR = 1.040, p = 0.032), and hyperlipidemia (OR = 3.040, p = 0.018).

CONCLUSION

CRstalk-avg may be the most sensitive parameter for quantifying VWE to identify PCI in patients with VBD, and it is also independently associated with PCI. BA diameter, BATI, and hyperlipidemia are independently associated with VWE.

Vessel wall imaging of vertebrobasilar artery configurations associated with posterior circulation infarction and high-risk atherosclerotic plaques

The geometric configuration of the vertebrobasilar artery (VBA) can influence hemodynamic changes in the posterior circulation. This study aims to analyze the correlation of vascular morphology with posterior circulation infarction (PCI) and high-risk plaques on vessel wall imaging (VWI). A total of 249 atherosclerotic inpatients with 530 plaque segments located in the basilar artery (BA) and vertebral artery (VA) were retrospectively enrolled, comprising 98 PCI and 151 non-PCI patients. The configurations of VBA were classified on VWI and 3-dimensional time-of-flight magnetic resonance angiography (3D TOF-MRA), with a further quantitative evaluation conducted on VWI. VWI achieved higher diagnostic accuracy in detecting tuning fork, walking, and lambda VBA configurations, and revealed increased sensitivity in diagnosing VA hypoplasia (VAH), compared to TOF-MRA. Higher proportions of PCI and high-risk plaques were observed in the lambda and walking configurations than the tuning fork. No statistical difference in VAH was observed between the PCI and non-PCI groups (P = .972). Multivariable logistic regression analysis revealed that high-risk plaque [odds ratio (OR) = 1.997 (1.039-3.837), P = .038], the mean diameter of bi-VAs [OR = 1.557(1.012-2.395), P = .044], and the grade of BA lateral position [OR = 1.416 (1.029-1.950), P = .033] were independent risk factors associated with PCI. High-risk plaque segments featured larger vascular diameter, wall area, normalized wall index (NWI), remodeling index (RI), plaque volume, BA-midline, and vessel length compared with those with low-risk plaques (all P < .05). VWI offers the dual advantages of observing vascular morphology and evaluating high-risk plaques, which aids in the timely identification of individuals with PCI risks.

Anatomical analysis of vertebral arteries in vertebrobasilar dolichoectasia: A multi-center study

BACKGROUND

Vertebrobasilar dolichoectasia (VBD) is a rare disease with significant morbidity. Its propensity for posterior circulation and relationship with aneurysms is poorly understood. Here, we aimed to describe the anatomical characteristics of the vertebral arteries (VA) in patients with VBD.

METHODS

We conducted a multi-center retrospective cohort analysis on patients diagnosed with VBD between January 2009 and December 2022. Anatomical variables were measured after manual segmentation on CTA. Length of the VAs, basilar artery (BA), sectional diameters, and tortuosity index were measured and compared with a control group.

RESULTS

124 patients were included: 38 patients with VBD and 86 controls. VBD patients had longer VAs (right VA 262.5 vs. 228.7 mm, p<0.01; left VA 253.4 vs. 222.1 mm, p<0.01), longer BAs (41.9 vs. 30.0 mm, p<0.01), and larger cross-sectional diameters of right V3 (5.1 vs. 4.6 mm, p<0.05) and V4 segments (4.5 vs.2.9 mm, p<0.05) and left V1-V4 segments (V1 6.1 vs. 4.2, V2 7.2 vs.4.8 mm, V3 6.4 vs.5.0 mm, V4 6.5 vs. 3.0 mm, p<0.01). Patients with VBD and fusiform aneurysms had longer VAs and BA than patients without aneurysms (p<0.01). The VAs tortuosity index was higher in VBD than controls (60.69 vs. 44.18, p<0.01). No cases of vertebral stenosis were detected.

CONCLUSIONS

Our study offers an anatomical study of VBD. While the natural history is poorly understood, the higher tortuosity index with associated wall shear stress, provides a possible mechanism for disease progression. Further studies are needed to better understand the.

Association of brain arterial diameters with demographic and anatomical factors in a multi-national pooled analysis of cohort studies

BACKGROUND AND PURPOSE

Brain arterial diameters are markers of cerebrovascular disease. Demographic and anatomical factors may influence arterial diameters. We hypothesize that age, sex, height, total cranial volume (TCV), and persistent fetal posterior cerebral artery (fPCA) correlate with brain arterial diameters across populations.

METHODS

Participants had a time-of-flight MRA from nine international cohorts. Arterial diameters of the cavernous internal carotid arteries (ICA), middle cerebral arteries (MCA), and basilar artery (BA) were measured using LAVA software. Regression models assessed the association between exposures and brain arterial diameters.

RESULTS

We included 6,518 participants (mean age: 70 ± 9 years; 41% men). Unilateral fPCA was present in 13.2% and bilateral in 3.2%. Larger ICA, MCA, and BA diameters correlated with older age (Weighted average [WA] per 10 years: 0.18 mm, 0.11 mm, and 0.12 mm), male sex (WA: 0.24 mm, 0.13 mm, and 0.21 mm), and TCV (WA: for one TCV standard deviation: 0.24 mm, 0.29 mm, and 0.18 mm). Unilateral and bilateral fPCAs showed a positive correlation with ICA diameters (WA: 0.39 mm and 0.73 mm) and negative correlation with BA diameters (WA: -0.88 mm and -1.73 mm). Regression models including age, sex, TCV, and fPCA explained on average 15%, 13%, and 25% of the ICA, MCA, and BA diameter interindividual variation, respectively. Using height instead of TCV as a surrogate of head size decreased the R-squared by 3% on average.

CONCLUSION

Brain arterial diameters correlated with age, sex, TCV, and fPCA. These factors should be considered when defining abnormal diameter cutoffs across populations.

Pathology-based brain arterial disease phenotypes and their radiographic correlates

INTRODUCTION

Brain arterial diseases, including atherosclerosis, vasculitis, and dissections, are major contributors to cerebrovascular morbidity and mortality worldwide. These diseases not only increase the risk of stroke but also play a significant role in neurodegeneration and dementia. Clear and unambiguous terminology and classification of brain arterial disease phenotypes is crucial for research and clinical practice.

MATERIAL AND METHODS

This review aims to summarize and harmonize the terminology used for brain large and small arterial phenotypes based on pathology studies and relate them to imaging phenotypes used in medical research and clinical practice.

CONCLUSIONS AND RESULTS

Arteriosclerosis refers to hardening of the arteries but does not specify the underlying etiology. Specific terms such as atherosclerosis, calcification, or non-atherosclerotic fibroplasia are preferred. Atherosclerosis is defined pathologically by an atheroma. Other brain arterial pathologies occur and should be distinguished from atherosclerosis given therapeutic implications. On brain imaging, intracranial arterial luminal stenosis is usually attributed to atherosclerosis in the presence of atherosclerotic risk factors but advanced high-resolution arterial wall imaging has the potential to more accurately identify the underlying pathology. Regarding small vessel disease, arteriosclerosis is ambiguous and arteriolosclerosis is often used to denote the involvement of arterioles rather than arteries. Lipohyalinosis is sometimes used synonymously with arteriolosclerosis, but less accurately describes this common small vessel thickening which uncommonly shows lipid. Specific measures of small vessel wall thickness, the relationship to the lumen as well as changes in the layer composition might convey objective, measurable data regarding the status of brain small vessels.

Prevalence of basilar artery dolichoectasia in patients with acute ischemic stroke or transient ischemic attack in a single center of Spain

INTRODUCTION

Basilar artery dolichoectasia (BADE) refers to abnormal enlargement or displacement of the basilar artery (BA). The previously reported prevalence of BADE among patients with stroke is 0.3 to 33.1%, however, it might vary among studied populations. We aim is to determine the prevalence of BADE in patients presenting with acute ischemic stroke (AIS) or transient ischemic attack (TIA) in a Stroke Unit in a single center in Spain.

PATIENTS AND METHODS

Patients 50 years old or older presenting with AIS or TIA were eligible for inclusion. Demographic and clinical data were prospectively collected. Two neuroradiologists, blind to each other, assessed BA morphology.

RESULTS

Among 126 patients, 34.1% fulfilled the criteria for BADE (ectasia or dolichosis). BADE was associated with advanced age (p = 0.04). Patients with fetal-type circle of Willis presented smaller BA diameters (2.9 ± 0.1 vs. 3.5 ± 0.1; p < 0.001), whereas patients with lacunar strokes presented a greater diameter than other stroke subtypes (3.8 ± 0.3 mm vs. 3.3 ± 0.1 mm; p = 0.04).

DISCUSSION AND CONCLUSIONS

In this single-center study of patients presenting with AIS or TIA, the prevalence of BADE (ectasia or dolichosis) is high. Further studies focusing on Spaniards should confirm our results.

Microcurrent wave alleviates mouse intracranial arterial dolichoectasia development

Intracranial arterial dolichoectasia (IADE) is associated with the interaction of hypertension and inflammation, and microcurrent can be effective in hypertension. Therefore, this study aimed to investigate the therapeutic effect of microcurrent electrical stimulation in a mouse IADE model. This study randomly categorized 20 mice into five groups: group 1-C (healthy control), group 2-D (IADE model), group 3-M + D (microcurrent administration before nephrectomy and until brain surgery), group 4-D + M (microcurrent administration for 4 weeks following brain surgery), and group 5-M (microcurrent administration for 4 weeks). Cerebral artery diameter and thickness and cerebral arterial wall extracellular matrix components were assessed. Among the five groups, group 2-D showed significantly higher cerebral arterial wall diameter (117.79 ± 17.05 µm) and proportion of collagen (42.46 ± 14.12%) and significantly lower arterial wall thickness (9.31 ± 2.26 µm) and proportion of smooth muscle cell (SMC) and elastin in the cerebral arterial wall (SMC: 38.05 ± 10.32%, elastin: 11.11 ± 6.97%). Additionally, group 4-D + M exhibited a non-significantly lower diameter (100.28 ± 25.99 µm) and higher thickness (12.82 ± 5.17 µm). Group 5-M demonstrated no evidence of toxicity in the liver and brain. The pilot study revealed that microcurrent is effective in preventing IADE development, although these beneficial effects warrant further investigation.

Relationships between intracranial arterial dolichoectasia and small vessel disease in patients with ischaemic stroke: a systematic review and meta-analysis

BACKGROUND

Intracranial arterial dolichoectasia (IADE) is a common arterial finding of dilation, elongation, or both, affecting large intracranial vessels, and associated with vascular risk factors, including hypertension. Associations of IADE with neuroimaging cerebral small vessel disease (CSVD) may be relevant for diagnosis and prognosis in patients with stroke. The study aimed to conduct an updated systematic review and meta-analysis of observational studies to investigate the relationships of IADE with well-defined CSVD markers in patients with ischaemic stroke.

METHODS

We systematically searched PubMed, Embase, and Scopus for studies on IADE in ischaemic stroke patients with fulfilling predefined inclusion criteria. We pooled data to conduct a meta-analysis to compare the prevalence of SVD markers between patients with and without IADE groups using risk ratios (RRs) and 95% confidence intervals (CIs).

RESULTS

From 157 retrieved abstracts, we included six studies from seven publications comprising 6102 patients with ischaemic stroke. The mean age of patients was 52.8 years, and 3691 (60.5%) were male. IADE was diagnosed in 11.4% (95% CI 8.9-13.9) (761) of included patients; 51.8% (3160) had hypertension. Compared to patients without IADE, individuals diagnosed with IADE had a significantly increased prevalence of lacune (RR 1.67, 95% CI 1.36-2.06, P < 0.01, I2 = 0.00%), cerebral microbleeds (CMBs) (RR 2.56, 95% CI 1.53-4.28, P < 0.01, I2 = 84.95%) and white matter hyperintensities (WMHs) (RR 2.17, 95% CI 1.84-2.56, P < 0.01, I2 = 0.00%).

CONCLUSIONS

In patients with ischaemic stroke, IADE is associated with a higher prevalence of CSVD markers, including lacunes, CMBs, and WMHs. Further studies are needed to clarify the mechanisms underlying these associations and their potential relevance for the understanding, diagnosis, and treatment of CSVD.

A Giant Stent for Giant Cerebral Aneurysms-The Accero®-Rex-Stent

OBJECTIVE

Until now, giant intracranial aneurysms (GIAs) have in many cases been a vascular disease that was difficult or impossible to treat, not least due to the lack of availability of a large-format stent. In this multicentre study, we report on the first five clinical applications of the Accero®-Rex-Stents (Acandis, Pforzheim, Germany) in the successful treatment of fusiform cerebral giant aneurysms.

MATERIAL AND METHODS

The Accero®-Rex-Stents are self-expanding, braided, fully radiopaque Nitinol stents designed for aneurysm treatment. The stent is available in three different sizes (diameter 7-10 mm, length 30-60 mm) and intended for endovascular implantation in vessels with diameters of 5.5-10 mm.

RESULTS

Five patients (all male, age 54.4 ± 8.1 years) with large fusiform aneurysms of the posterior circulation were treated endovascularly using the Accero®-Rex-Stents. There were no technical complications. One major ischemic complication occurred. A significant remodeling and reduction in the size of the stent-covered aneurysms was already seen in the short-term post-interventional course.

CONCLUSIONS

The Accero®-Rex-Stents were successfully and safely implanted in all five patients with fusiform giant aneurysms, showing technical feasibility with promising initial results and significant aneurysm size reduction in already available follow-up imaging.

KEY POINT

With the Accero-Rex-Stents, a new device is available that offers another treatment option for rare cerebral fusiform giant aneurysms with very large parent vessels.

Dolichoectasia of vertebrobasilar artery presenting as facial pain: a case report

Dolichoectasia of the intracranial arteries is a rare condition characterized by elongated and tortuous arteries due to progressive destruction of the vessel walls. Although most patients present with cerebrovascular accidents, our patient presented with intractable facial pain along the distribution of the trigeminal nerve. Clinical examination revealed involvement of the 5th, 7th, and 8th cranial nerves, and subsequent MRI showed dolichoectasia of the left basilar artery. The patient experienced symptomatic relief after a trial of carbamazepine along with botulinum toxin injections.

Three-dimensional aneurysm wall enhancement in fusiform intracranial aneurysms is associated with aneurysmal symptoms

Background and purpose

Aneurysm wall enhancement (AWE) in high-resolution magnetic resonance imaging (HR-MRI) is a potential biomarker for evaluating unstable aneurysms. Fusiform intracranial aneurysms (FIAs) frequently have a complex and curved structure. We aimed to develop a new three-dimensional (3D) aneurysmal wall enhancement (AWE) characterization method to enable comprehensive FIA evaluation and to investigate the ability of 3D-AWE to predict symptomatic FIA.

Methods

We prospectively recruited patients with unruptured FIAs and received 3 T HR-MRI imaging from September 2017 to January 2019. 3D models of aneurysms and parent arteries were generated. Boundaries of the FIA were determined using 3D vessel diameter measurements. D_max was the greatest diameter in the cross-section, while L_max was the length of the centerline of the aneurysm. Signal intensity of the FIA was normalized to the pituitary stalk and then mapped onto the 3D model, then the average enhancement (3D-AWE_avg), maximum enhancement (3D-AWE_max), enhancement area (AWE_area), and enhancement ratio (AWE_ratio) were calculated as AWE indicators, and the surface area of the entire aneurysm (A_area) was also calculated. Areas with high AWE were defined as those with a value >0.9 times the signal intensity of the pituitary stalk. Multivariable logistic regression analyses were performed to determine independent predictors of aneurysm-related symptoms. FIA subtypes were defined as fusiform, dolichoectasia, and transitional. Differences between the three FIA subtypes were also examined.

Results

Forty-seven patients with 47 FIAs were included. Mean patient age was 55 ± 12.62 years and 74.5% were male. Twenty-nine patients (38.3%) were symptomatic. After adjusting for baseline differences in age, hypertension, L_max, and FIA subtype, the multivariate logistics regression models showed that 3D-AWE_avg (odds ratio [OR], 4.029; p = 0.019), 3D-AWE_max (OR, 3.437; p = 0.022), AWE_area (OR, 1.019; p = 0.008), and AWE_ratio (OR, 2.490; p = 0.045) were independent predictors of aneurysm-related symptoms. D_max and A_area were larger and 3D-AWE_avg, 3D-AWE_max, AWE_area, and AWE_ratio were higher with the transitional subtype than the other two subtypes.

Conclusion

The new 3D AWE method, which enables the use of numerous new metrics, can predict symptomatic FIAs. Different 3D-AWE between the three FIA subtypes may be helpful in understanding the pathophysiology of FIAs.

Association of Brain Arterial Elongation With Risk of Stroke and Death in Stroke-Free Individuals: Results From NOMAS

BACKGROUND

Brain arterial dilation and elongation characterize dolichoectasia, an arteriopathy associated with risk of stroke and death. We aim to determine whether brain arterial elongation increases the risk of stroke and death independent of brain arterial diameters.

METHODS

We analyzed 1210 stroke-free participants (mean age 71±9 years, 41% men, 65% Hispanic) with available time-of-flight magnetic resonance angiogram from the Northern Manhattan Study, a population-based cohort study across a multiethnic urban community. We obtained baseline middle cerebral artery M1-segment (MCA-M1) and basilar artery (BA) mean lengths and diameters using a semi-automated software. Cox proportional hazards models adjusted for brain arterial diameters and potential confounders yielded adjusted hazards ratios with 95% CIs for the primary outcomes of incident stroke and all-cause mortality, as well as secondary outcomes including noncardioembolic stroke, vascular death, and any vascular event.

RESULTS

Neither MCA-M1 nor BA lengths correlated with incident stroke or all-cause mortality. Both MCA-M1 and BA larger diameters correlated with all-cause mortality (MCA-M1 aHR, 1.52 [95% CI, 1.03-2.23], BA aHR, 1.28 [95% CI, 1.02-1.61]), as well as larger MCA-M1 diameters with vascular death (aHR, 1.84 [95% CI, 1.02-3.31]). Larger MCA-M1 and BA diameters did not correlate with incident stroke. However, larger BA diameters were associated with posterior circulation noncardioembolic stroke (aHR, 2.93 [95% CI, 1.07-8.04]). There were no statistical interactions between brain arterial lengths and diameters in relation to study outcomes.

CONCLUSIONS

In a multiethnic cohort of stroke-free adults, brain arterial elongation did not correlate with risk of stroke or death, nor influenced the significant association between brain arterial dilation and vascular risk.

Studying the imaging features and infarction mechanism of vertebrobasilar dolichoectasia with high-resolution magnetic resonance imaging

The mechanisms underlying ischemic infarction in patients with vertebrobasilar dolichoectasia (VBD) remain unclear. In this study, we retrospectively analyzed the imaging characteristics of high-resolution magnetic resonance imaging (HR-MRI) in patients with VBD to explore the possible mechanisms of ischemic stroke (IS) in patients with VBD. Patients with VBD were recruited from the HR-MRI database between July 2017 and June 2021. HR-MRI was used to evaluate the diameter, bifurcation height, laterality, arterial dissection, and atherosclerotic plaques of the basilar artery (BA). Transcranial Doppler was used to measure the vertebrobasilar mean velocity (Vm), peak systolic velocity (Vs), end-diastolic velocity (Vd), and pulsatile index. Twenty-six patients with VBD were enrolled, of which 15 had IS and 11 did not. The incidence of classical vascular risk factors, including age, sex, hypertension, diabetes, and hypercholesterolemia, did not differ significantly between the two groups. The BA diameters of the stroke group were significantly higher than that of the nonstroke group (6.57 ± 1.00 mm vs. 5.06 ± 0.50 mm, p = 0.000). The height of the BA bifurcation in the stroke and nonstroke groups was statistically significant (p = 0.002). Compared with the nonstroke group, the Vm, Vs, and Vd of the BA in the stroke group were lower, but the difference was not significant. In the 16 patients with atherosclerotic stenosis, 30 atherosclerotic plaques were found in the BA, 18 (60%) in the greater curvature, and 12 (40%) in the lesser curvature. In addition, one artery dissection (on the lesser curvature) and two dissecting aneurysms (on the greater curvature) were found in the BA of three patients, respectively. The BA diameter and bifurcation height are factors related to IS in patients with VBD. The mechanism of stroke in patients with VBD may involve abnormal hemodynamics, artery dissection, and atherosclerosis. HR-MRI is a useful method for evaluating the risk and underlying mechanism of stroke in patients with VBD.

Prospects and Dilemmas of Endovascular Treatment for Vertebrobasilar Dolichoectasia

Vertebrobasilar dolichoectasia (VBD) is characterized by significant expansion, elongation, and tortuosity of the basilar artery and vertebral artery. Certain highly selected cases of VBD can require intervention. Recent advances in endovascular treatment (EVT) have renewed hope for patients with VBD. However, which cases of VBD can benefit from EVT still needs to be determined. Currently, little is known regarding this matter. Therefore, we performed a review of the literature from a PubMed search and cataloged our experience regarding the classification and natural history of VBD and the prospects, prognosis and complications of EVT. The findings can be summarized as follows: for asymptomatic VBD, “wait and see” or medical management may be a reasonable strategy. EVT may only be effective in certain patients. For saccular aneurysms in VBD, especially ruptured aneurysms, EVT is reasonable. For fusiform aneurysms in VBD, EVT can carry high complication rates and should be recommended with caution. For stenting reconstruction in VBD, the effect is uncertain. For the future of EVT of VBD, randomized controlled trials and the development of neurointerventional products are worth pursuing, but EVT in VBD still has a long way to go.

Dolichoectasia: a brain arterial disease with an elusive treatment

INTRODUCTION

Dolichoectasia is a form of brain large artery disease associated with a high risk of mortality and morbidity. Progressive enlargement of arterial size is a predictor of mortality, but there are no specific treatments for arresting or slowing down dilatation. Additionally, dilated brain arteries can cause flow stagnation, which can trigger thrombosis and cause stroke. Pathology and genetic studies indicate a possible role for increased matrix metalloproteinase activation in arterial dilatation and thus in the pathophysiology of dolichoectasia. Therefore, therapeutic interventions aimed at slowing down arterial dilatation and preventing thrombosis could hypothetically play a role in treating patients with dolichoectasia.

METHODS

We present four patients with dolichoectasia that exemplify therapeutic challenges worth discussing in the context of the current literature. Two patients were treated off-label with doxycycline (based on its antiMMP properties) and with apixaban, one patient was put on warfarin and later switched to aspirin, and the fourth patient underwent endovascular treatment.

RESULTS

We report four cases, all men 50 years or older. Of the two patients treated with doxycycline, we noted a slowdown of the basilar artery (BA) growth, but the BA continued to grow in the other patient. Of the two patients who received apixaban, none had a subsequent stroke in 5 and 4 years of follow-up, respectively. One patient was admitted with a fatal BA thrombosis and rupture, and pathological examination of the brain arteries demonstrated advanced arterial wall degeneration but no atherosclerosis.

DISCUSSION

These cases exemplify the challenges of treating people with dolichoectasia and highlight the need for better evidence regarding the best possible treatment for this population.